Ge Healthcare Technologies Inc Stock

GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration (FDA) has approved an updated label for its positron emission tomography (PET) imaging agent Vizamyl^TM

GE HealthCare (Nasdaq: GEHC) announced the introduction of Genesis™ Radiology Workspace, a next-generation solution designed to transform radiology workflows, unify the user experience, and empower

The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the fourth quarter of 2025 payable on February 13

GE HealthCare (Nasdaq: GEHC) announced it has entered into an agreement to acquire Intelerad, a leading medical imaging software provider for the healthcare industry, for a purchase price of $2.3

GE HealthCare (Nasdaq: GEHC) management will present at the following upcoming investor conference.

• 
  Jefferies Global Healthcare Conference in London, England – Tuesday, November 18, 2025 at

GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conference.

• 
  Jefferies Global Healthcare Conference in London

GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2025.

GE HealthCare President and CEO Peter Arduini said, “We delivered robust orders with

GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2025 financial results before the market opens on Wednesday, October 29, 2025. The GE HealthCare management team will also host a

The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the third quarter of 2025 payable on November 14

GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences.

• 
  2025 Wells Fargo Healthcare Conference – Thursday

GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2025.

GE HealthCare President and CEO Peter Arduini said, “We were pleased with solid orders

GE HealthCare (Nasdaq: GEHC) will announce its second quarter 2025 financial results before the market opens on Wednesday, July 30, 2025. The GE HealthCare management team will also host a

The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2025 payable on August 15, 2025

GE HealthCare’s commitment to advancing precision care in cardiology through innovative molecular imaging solutions is on full display at this week’s Society of Nuclear Medicine and Molecular

At this year’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfolio of

Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions being the development